XML 57 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements - Unobservable Input Reconciliation of Contingent Consideration Liability (Details) - Fair Value, Inputs, Level 3 - Contingent Consideration Liabilities - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Oct. 01, 2016
Jul. 02, 2016
Apr. 02, 2016
Jan. 02, 2016
Contingent Consideration Liability [Roll Forward]        
Beginning balance $ 31 $ 36 $ 151 $ 50
Initial fair value measurement of contingent consideration 4     155
Liabilities assumed from Thoratec acquisition       33
Change in fair value of contingent consideration 5 (5) 9 (87)
Transfer out of Level 3 fair value measurement due to contractual settlement     (124)  
Ending balance 40 31 36 151
Nanostim        
Contingent Consideration Liability [Roll Forward]        
Beginning balance 2 2 2 50
Initial fair value measurement of contingent consideration 0     0
Liabilities assumed from Thoratec acquisition       0
Change in fair value of contingent consideration 0 0 0 (48)
Transfer out of Level 3 fair value measurement due to contractual settlement     0  
Ending balance 2 2 2 2
Spinal Modulation        
Contingent Consideration Liability [Roll Forward]        
Beginning balance 2 6 122 0
Initial fair value measurement of contingent consideration 0     155
Liabilities assumed from Thoratec acquisition       0
Change in fair value of contingent consideration 5 (4) 8 (33)
Transfer out of Level 3 fair value measurement due to contractual settlement     (124)  
Ending balance 7 2 6 122
Thoratec        
Contingent Consideration Liability [Roll Forward]        
Beginning balance 27 28 27 0
Initial fair value measurement of contingent consideration 0     0
Liabilities assumed from Thoratec acquisition       33
Change in fair value of contingent consideration 0 (1) 1 (6)
Transfer out of Level 3 fair value measurement due to contractual settlement     0  
Ending balance 27 27 28 27
U.S. Distributor        
Contingent Consideration Liability [Roll Forward]        
Beginning balance 0 0 0 0
Initial fair value measurement of contingent consideration 4     0
Liabilities assumed from Thoratec acquisition       0
Change in fair value of contingent consideration 0 0 0 0
Transfer out of Level 3 fair value measurement due to contractual settlement     0  
Ending balance $ 4 $ 0 $ 0 $ 0